Date: October 19, 2026
Time: 3:45 pm to 5:15 pm
Room: Sandpiper Salons A&B
Track: Traditional Special Interest Group (SIG)
Cerebrovascular disease remains a rapidly evolving field, with ongoing advances shaping prevention, treatment, and outcomes. This session will highlight late-breaking developments in secondary stroke prevention, intracerebral hemorrhage (ICH), and sex-specific risk factors in stroke.
Presentations will examine factors unique to women that influence stroke risk, treatment, and participation in research, with particular emphasis on pregnancy and menopause. The session will also review recent progress in ICH management, including emerging evidence supporting minimally invasive surgical approaches, rapid triage strategies, and comprehensive care bundles aimed at improving outcomes in this high-mortality condition.
In addition, the evolving role of Factor XI inhibitors will be discussed as a promising strategy for targeted stroke prevention, with the potential to reduce recurrence while minimizing bleeding risk.
The session will also feature presentations from authors of two top-scoring ANA2026 abstracts, along with a third presentation highlighting an early-career investigator (e.g., trainee, Instructor, Assistant Professor, or participant from a low- and middle-income country) to support emerging researchers and foster continued engagement with the ANA.
At the conclusion of this session, attendees will be able to:
In this presentation, Dr. Bushnell will cover sex-specific factors, such as menopausal symptoms, treatment with hormone therapy, and history of pregnancy complications.
In this presentation, Dr. Mayer will provide an overview of the most promising present and future advances in emergency intervention for acute intracerebral hemorrhage.
Coming Soon